The Heart Guard technology is a system for continual measurement of cardiac metabolism. Heart Guard is designed to support controlled cardiac arrest (cardioplegic arrest) during heart surgery. Heart Guard has the potential to reduce mortality and the rate of severe complications resulting from a suboptimal cardioplegia effect on the cellular level. Proof of principle is confirmed.
The project is ongoing and the technology will approache TRL 6 (technology readiness level: 6).
The first financial round investment in the project was made by the YouNick fund and the National Centre for Research and Development as part of the Bridge Alfa program.
Project website: www.heartguard.pl